The Baylor College of Medicine experience with gold seed implantation

Seminars in Surgical Oncology

Volumn 13, Issue 6, 1997, Pages 406-418

  Butler, E Brian ^a,c   Scardino, Peter T ^a   Teh, Bin S ^a   Uhl, Barry M ^a   Guerriero, W Graham ^a   Carlton, C Eugene ^a   Berner, Barry M ^a   Dennis, W Sam ^a   Carpenter, L Steven ^a   Lu, Hsin H ^a   Chiu, J Kam ^a   Kent, T Spencer ^b   Woo, Shiao Y ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Brachytherapy; Gold radioisotopes; Interventional ultrasonography; Iodine radioisotopes; Palladium isotopes; Prostatic neoplasms; Radiotherapy

Indexed keywords

GOLD;

ARTICLE; CANCER CONTROL; DOSE CALCULATION; DOSIMETRY; HALF LIFE TIME; HUMAN; IMPLANTATION; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECURRENT DISEASE; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; GOLD RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 9844250755     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199711/12)13:6<406::AID-SSU4>3.0.CO;2-E     Document Type: Article

References (10)

1. Flocks RH, Kerr HD, Elkins HB, Culp DA: Treatment of carcinoma of the prostate by interstitial radiation with radioactive gold (Au-198): a preliminary report. J Urol 1952;68:510-522.
2. Guerriero WG, Carlton CE Jr, Hudgins PT: Combined interstitial and external radiotherapy in the definitive management of carcinoma of the prostate. Cancer 1980;45(7 Suppl):1922-1923.
3. Whitmore WF Jr, Hilaris B, Sogani P, et al: Interstitial irradiation using I-125 seeds. Prog Clin Biol Res 1987;243B:177-195.
4. Kuban DA, El-Mahdi AM, Schellhammer PF: I-125 interstitial implantation for prostate cancer. What have we learned 10 years later? Cancer 1989;63:2415-2420.
5. Blasko JC, Ragde H, Schumacher D: Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether/Hypertherm Oncol 1987;3:131-139.
6. Blasko JC, Grimm PD, Ragde H: Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin Radiat Oncol 1993;3:240-249.
7. Wallner K: Iodine-125 brachytherapy for early stage prostate cancer: new techniques may achieve better results. [Review] Oncology 1991;5:115-122, discussion 122, 125-126.
8. Wallner K: Brachytherapy for Prostate Cancer; ASTRO refresher course #304. Thirty-eighth annual meeting of the American Society for Therapeutic Radiology and Oncology, 1996 Oct 27-30; Los Angeles Los Angeles, CA.
9. Bagshaw MA: Radiation therapy for cancer of the prostate. In Skinner DG, Lieskovsky G (eds): "Diagnosis and management of genitourinary cancer". Philadelphia: WB Saunders, 1988:425-445.
10. Cox JD, Grignon DJ, Kaplan RS, et al: Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.